The new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences

Re:GEN Open combines the dynamic, global media presence of Genetic Engineering & Biotechnology News (GEN) with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer review, and international exposure for your work.

basic biomedical research
translational biomedical research
Synthetic and Systems Biology
regenerative medicine
cancer research
drug development
cell and gene therapy
infectious disease

The only choice for your next manuscript

The things that matter to you are the things that matter to us: speed, credibility, authority, visibility, and discoverability.

Re:GEN Open is the home for your next manuscript.

Submit Your Manuscript

Announcements

01 Apr 2021

Call for Editorial Board Members

We are recruiting Editorial Board Members to join Re:GEN Open! If you are interested in giving back to the scientific community and have a scientific background in the life or medical sciences, please contact editorial@regenopen.com for more information.